Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Bando Chemical, The Current Fiscal Year Net Income Revised Downward to an Unexpected 19% Decrease
5195 Bando Chemical Industries, Ltd. 【IFRS】
Earnings ReportBando Chemical Industries, Ltd. <5195> [TSE Prime] announced its financial results (based on IFRS) in the afternoon session on February 10th (14:00). The consolidated net income for the cumulative third quarter of the fiscal year ending March 2025 (April to December) decreased 15.0% from the same period last year to 4.24 billion yen.
In addition, the full-year consolidated net income has decreased 23.1%, from the previous forecast of 6.5 billion yen to 5 billion yen (compared to 6.18 billion yen in the previous period). This changes the outlook from an anticipated profit increase to a projection of a 19.1% decrease in profit.
Based on the full-year plan announced by the company after the downward revision, our estimate of the consolidated net income for the October to March period (2H) has decreased 46.8%, from the previous forecast of 3.2 billion yen to 1.7 billion yen (compared to 2.5 billion yen in the same period of the previous year). This changes the outlook from an anticipated profit increase to a projection of a 32.1% decrease in profit.
In the most recent three-month period, from October to December (3Q), the consolidated net income decreased to 0.94 billion yen, a 28.5% decrease compared to the same period last year. The operating profit margin drastically worsened from 9.0% in the same period last year to 3.2%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 78,301 | 6,724 | 7,034 | 4,605 | 104.3 | 82.3 | Feb 8, 2023 | IFRS |
Apr - Dec, 2023 | 80,700 | 6,915 | 7,422 | 4,992 | 114.9 | 85.5 | Feb 9, 2024 | IFRS |
Apr - Dec, 2024 | 87,275 | 5,994 | 6,376 | 4,242 | 99.8 | ー | Feb 10, 2025 | IFRS |
YoY | +8.1% | -13.3% | -14.1% | -15.0% | -13.2% |
Guidance Update
Second Half Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2024 Prev | 51,902 | 4,552 | ー | 3,203 | 76.7 | 38 | Nov 8, 2024 | IFRS |
Oct - Mar, 2024 New | 51,902 | 2,452 | ー | 1,703 | 40.8 | 38 | Feb 10, 2025 | IFRS |
Revision Rate | 0.0% | -46.1% | - | -46.8% | -46.8% |
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Prev | 110,000 | 9,600 | ー | 6,500 | 155.5 | 76 | May 15, 2024 | IFRS |
Mar, 2025 New | 110,000 | 7,500 | ー | 5,000 | 119.7 | 76 | Feb 10, 2025 | IFRS |
Revision Rate | 0.0% | -21.9% | - | -23.1% | -23.1% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 54,351 | 3,257 | 3,268 | 2,509 | 57.9 | 38 | May 15, 2024 | IFRS |
Oct - Mar, 2024 Guidance | 51,902 | 2,452 | ー | 1,703 | 40.8 | 38 | Feb 10, 2025 | IFRS |
YoY | -4.5% | -24.7% | - | -32.1% | -29.6% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 103,608 | 8,259 | 8,542 | 5,722 | 130.0 | 52 | May 15, 2023 | IFRS |
Mar, 2024 | 108,278 | 7,772 | 8,676 | 6,180 | 142.6 | 72 | May 15, 2024 | IFRS |
Mar, 2025 Guidance | 110,000 | 7,500 | ー | 5,000 | 119.7 | 76 | Feb 10, 2025 | IFRS |
YoY | +1.6% | -3.5% | - | -19.1% | -16.1% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 26,773 | 2,400 | 2,014 | 1,321 | 30.4 | 9.0 | Feb 9, 2024 | IFRS |
Jan - Mar, 2024 | 27,578 | 857 | 1,254 | 1,188 | 27.4 | 3.1 | May 15, 2024 | IFRS |
Apr - Jun, 2024 | 29,344 | 2,292 | 2,857 | 1,932 | 45.1 | 7.8 | Aug 9, 2024 | IFRS |
Jul - Sep, 2024 | 28,754 | 2,756 | 1,668 | 1,365 | 32.0 | 9.6 | Nov 8, 2024 | IFRS |
Oct - Dec, 2024 | 29,177 | 946 | 1,851 | 945 | 22.2 | 3.2 | Feb 10, 2025 | IFRS |
YoY | +9.0% | -60.6% | -8.1% | -28.5% | -26.9% |
Related Articles
TSURUMI MANUFACTURING, Oct-Dec (3Q) Ordinary Profit Increases by 2.8 times
North Pacific Bank, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 35%
NIHON NOHYAKU, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 72%, Oct-Dec Ordinary Profit Increases by 3.1 times
Achilles, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 19 times, Exceeds Full-Year Plan
HOKURIKU ELECTRIC INDUSTRY, Oct-Dec (3Q) Ordinary Profit Increases by 2.9 times
Meiji Holdings, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 5%, Oct-Dec Ordinary Profit Decreases by 13%
NICHIBAN, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 32%
NISSIN SHOJI, The Current Fiscal Year Ordinary Profit Revised Upward by 9%
TAKAYOSHI Holdings, Oct-Dec (1Q) Ordinary Profit Decreases by 22%
Fuso Pharma, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 83%, Oct-Dec Ordinary Profit Increases by 64%